KIMBERLY CHAMBERS: Open Payments
NPI 1982977294 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,456 in 69 payments from 10 companies in 2025. Trend: 2023 $937 · 2024 $1,351 · 2025 $1,456
Food & beverage: $1,456
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $293 |
| ABBVIE INC. | 12 | $267 |
| PFIZER INC. | 19 | $231 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $198 |
| Vanda Pharmaceuticals Inc. | 4 | $129 |
| Xeris Pharmaceuticals, Inc. | 3 | $102 |
| Novo Nordisk Inc | 5 | $97 |
| Paratek Pharmaceuticals, Inc. | 3 | $68 |
| Lilly USA, LLC | 2 | $44 |
| Alkermes, Inc. | 1 | $27 |
Products named: NURTEC ODT, CAPLYTA, QULIPTA, FARXIGA, HETLIOZ, GVOKE HYPOPEN, BREZTRI, NUZYRA.
Industry payments across TN — which companies pay providers there.
